NEOPLASMA
Article List
Volume 52, 2005, No. 2
ISSN 0028-2685 (print)
ISSN 1338-4317 (online)
Content:
- ODRAZKA, K. - PETERA, J. - ZOUHAR, M. - VOSMIK, M. - VACULIKOVA, M. - DOLEZEL, M. - KOHLOVA, T. - FILIP, S. - CERAL, J. - HOBZA, V. - REHAK, S. - DOLEZAL, J.: Clinical results of intensity-modulated radiation therapy (IMRT) for tumors of the head and neck region. (p. 85)
- NEMETH, Z. - VELICH, N. - BOGDAN, s. - UJPAL, M. - SZABO, G. - SUBA, Z.: The prognostic role of clinical, morphological and molecular markers in oral squamous cell tumors. (p. 95)
- MLYNCEK, M. - UHARCEK, P.: Peritoneal cytology in endometrial cancer. (p. 103)
- DANESHBOD, Y. - AMIRGHOFRAN, Z. - TABEI, S.: Bcl-2 expression in acute myelogenous leukemia: the relation to myeloid antigen expression and response to therapy in Iranian patients. (p. 109)
- BERSTEIN, L. - ZIMARINA, T. - KOVALEVSKIJ, A. - MAXIMOV, S. - VOLKOV, O. - THIJSSEN, J.: CYP19 gene expression and aromatase activity in endometrial cancer tissue: importance of the type of the disease. (p. 115)
- MORAVCOVA, J. - REGNER, J. - MOUCKOVA, D. - FISER, K. - ZMEKOVA, V. - MALACOVA, R. - MICHALOVA, K. - KLAMOVA, H.: Disease status in patients with chronic myeloid leukemia is better characterized by BCR-ABL/BCR transcript ratio than by BCR-ABL transcript level, which may suggest a role of normal BCR gene in the disease pathogenesis. (p. 119)
- STRAKOVA, N. - EHRMANN, J. - BARTOS, J. - MALIKOVA, J. - DOLEZEL, J. - KOLAR, Z.: Peroxisome proliferator-activated receptors (PPAR) agonists affect cell viability, apoptosis and expression of cell cycle related proteins in cell lines of glial brain tumors. (p. 126)
- SKAPOVA, D. - RACIL, Z. - DVORAKOVA, D. - MINARIKOVA, D. - MAYER, J.: Significance of qualitative PCR detection method for preemptive therapy of cytomegalovirus infection in patiens after allogeneic hematopoietic stem cell transplantation - single-centre experience. (p. 137)
- MISZCZYK, L. - WOZNIAK, G. - TARNAWSKI, R. - MACIEJEWSKI, B.: Split-course accelerated hyperfractionation (CHA-CHA) for advanced head and neck cancers - preliminary results. (p. 143)
- PANAGIOTOU, I. - BROUNTZOS, E. - KELEKIS, D. - PAPATHANASIOU, M. - BAFALOUKOS, D.: Cerebral metastases of malignant melanoma: contemporary treatment modalities and survival outcome. (p. 150)
- MEGO, M. - EBRINGER, L. - DRGONA, L. - MARDIAK, J. - TRUPL, J. - GREKSAK, R. - NEMOVA, I. - ORAVCOVA, E. - Zajac, V. - KOZA, I.: Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Pilot study phase I. (p. 159)
- BUDIHNA, M. - SOBA, E. - SMID, L. - ZAKOTNIK, B. - STROJAN, P. - CEMAZAR, M. - FAJDIGA, I. - ZARGI, M. - ZUPEVC, A. - LESNICAR, H.: Inoperable oropharyngeal carcinoma treated with concomitant irradiation, mitomycin C and bleomycin - long term results. (p. 165)
- DMOSZYNSKA, A. - PODHORECKA, M. - MANKO, J. - BOJARSKA-JUNAK, A. - ROLINSKI, J. - SKOMRA, D.: The influence of thalidomide therapy on cytokine secretion, immunophenotype, BCL-2 expression and microvessel density in patients with resistant or relapsed multiple myeloma. (p. 175)
- WROBEL, T. - MAZUR, G. - KAPELKO, K. - KULICZKOWSKI, K.: Endostatin serum level in acute myeloid leukemia . (p. 182)